Clinical significance of activity of ALT enzyme in patients with hepatitis C virus

World Journal of Gastroenterology

Volumn 13, Issue 41, 2007, Pages 5481-5485

  Akkaya, Onder ^a   Kiyici, Murat ^a   Yilmaz, Yusuf ^a   Ulukaya, Engin ^a   Yerci, Omer ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Disease duration; Hepatitis C virus; Inflammation; Normal alanine aminotransferase; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIVARIATE ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; ECHOGRAPHY; ENZYME ACTIVITY; FATTY LIVER; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LIVER NECROSIS; MALE; MULTIVARIATE ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; VIRUS LOAD;

EID: 35348946339     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i41.5481     Document Type: Article

References (30)

1. Hughes CA, Shafran SD. Chronic hepatitis C virus management: 2000-2005 update. Ann Pharmacother 2006; 40:74-82
2. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol 2007; 13:2461-2466
3. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and virologic tests and clinical diagnosis of HCV-related liver disease. Int J Med Sci 2006; 3:35-40
4. Sievert W. Management issues in chronic viral hepatitis: hepatitis C. J Gastroenterol Hepatol 2002; 17:415-422
5. Teoh NC, Farrell GC. Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J 2004; 34:324-337
6. Sherman M. Chronic hepatitis C and screening for hepatocellular carcinoma. Clin Liver Dis 2006; 10:735-752
7. Liu C. Hepatitis C virus: virology and experimental systems. Clin Liver Dis 2006; 10:773-791
8. Beld M, Penning M, McMorrow M, Gorgels J, van den Hoek A, Goudsmit J. Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels. J Clin Microbiol 1998; 36:872-877
9. Mateescu RB, Rimbas M, Staniceanu F, Zurac S, Dragomir P, Voiosu MR, Tataru M, Zota M, Bucurica S. Histological and nonhistological criteria in the evaluation of liver involvement in chronic hepatitis C. Rom J Intern Med 2006; 44:117-130
10. Al-Quaiz MN, Madani TA, Karawi MA. The natural history of hepatitis C virus infection. Saudi Med J 2003; 24 Suppl 2: S67-S70
11. Mohamadnejad M, Pourshams A, Malekzadeh R, Mohamadkhani A, Rajabiani A, Asgari AA, Alimohamadi SM, Razjooyan H, Mamar-Abadi M. Healthy ranges of serum alanine aminotransferase levels in Iranian blood donors. World J Gastroenterol 2003; 9:2322-2324
12. Prati D, Taioli E, Zanella A, Della Torre E, Butelli S, Del Vecchio E, Vianello L, Zanuso F, Mozzi F, Milani S, Conte D, Colombo M, Sirchia G. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137:1-10
13. Puoti C, Castellacci R, Montagnese F. Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? Dig Liver Dis 2000; 32:634-643
14. Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, Rodriguez-Torres M, Lardelli P, Blotner S, Zeuzem S. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006; 4:645-652
15. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19:1513-1520
17. McCormick SE, Goodman ZD, Maydonovitch CL, Sjogren MH. Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C. Am J Gastroenterol 1996; 91:1516-1522
18. Ito H, Yoshioka K, Ukai K, Watanabe K, Yano M, Ishigami M, Mizutani T, Sasaki Y, Katano Y, Goto H. The fluctuations of viral load and serum alanine aminotransferase levels in chronic hepatitis C. Hepatol Res 2004; 30:11-17
19. Hassan MI, Kassim SK, Ali HS, Sayed el-DA, Khalifa A. Evaluation of nitric oxide (NO) levels in hepatitis C virus (HCV) infection: relationship to schistosomiasis and liver cirrhosis among Egyptian patients. Dis Markers 2002; 18:137-142
20. Butt AA, Tsevat J, Ahmad J, Shakil AO, Mrus JM. Biochemical and virologic parameters in patients co-infected with hepatitis C and HIV versus patients with hepatitis C mono-infection. Am J Med Sci 2007; 333:271-275
21. Haydon GH, Jarvis LM, Blair CS, Simmonds P, Harrison DJ, Simpson KJ, Hayes PC. Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection. Gut 1998; 42:570-575
22. Gholson CF, Morgan K, Catinis G, Favrot D, Taylor B, Gonzalez E, Balart L. Chronic hepatitis C with normal aminotransferase levels: a clinical histologic study. Am J Gastroenterol 1997; 92:1788-1792
23. Persico M, Perrotta S, Persico E, Terracciano L, Folgori A, Ruggeri L, Nicosia A, Vecchione R, Mura VL, Masarone M, Torella R. Hepatitis C virus carriers with persistently normal ALT levels: biological peculiarities and update of the natural history of liver disease at 10 years. J Viral Hepat 2006; 13:290-296
24. Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, Rodriguez-Torres M, Lardelli P, Blotner S, Zeuzem S. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006; 4:645-652
25. Lozano M, Cid J, Bedini JL, Mazzara R, Gimenez N, Mas E, Ballesta A, Ordinas A. Study of serum alanine-aminotransferase levels in blood donors in Spain. Haematologica 1998; 83:237-239
26. Khedmat H, Fallahian F, Abolghasemi H, Hajibeigi B, Attarchi Z, Alaeddini F, Holisaz MT, Pourali M, Sharifi S, Zarei N. Serum gamma-glutamyltransferase, alanine aminotransferase, and aspartate aminotransferase activity in Iranian healthy blood donor men. World J Gastroenterol 2007; 13:889-894
27. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, Sansonetti N, Opolon P. Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group. Hepatology 1998; 27:1213-1219
28. Brinkmann T, Dreier J, Diekmann J, Gotting C, Klauke R, Schumann G, Kleesiek K. Alanine aminotransferase cut-off values for blood donor screening using the new International Federation of Clinical Chemistry reference method at 37 degrees C. Vox Sang 2003; 85:159-164
29. Tsai JF, Jeng JE, Ho MS, Wang CS, Chang WY, Hsieh MY, Lin ZY, Tsai JH. Serum alanine aminotransferase level in relation to hepatitis B and C virus infections among blood donors. Liver 1997; 17:24-29
30. Kariv R, Leshno M, Beth-Or A, Strul H, Blendis L, Kokia E, Noff D, Zelber-Sagie S, Sheinberg B, Oren R, Halpern Z. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study. Liver Int 2006; 26:445-450